Knockdown of ezrin via RNA interference suppresses Helicobacter pylori-enhanced invasion of gastric cancer cells

Cancer Biology and Therapy

Volumn 11, Issue 8, 2011, Pages 746-752

  Fan, Li Lin ^a   Chen, Dong Feng ^c   Lan, Chun Hui ^c   Liu, Kai Yun ^b   Fang, Dian Chun ^a  

^a SOUTHWEST HOSPITAL   (China)

^b Department of Clinical Immunology   (China)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Ezrin; Gastric cancer; Helicobacter pylori; Invasion; RNAi

Indexed keywords

ANTIBIOTIC G 418; EZRIN; PLASMID VECTOR;

ARTICLE; CANCER CELL; CANCER INVASION; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL STRUCTURE; COCULTURE; CONTROLLED STUDY; GENETIC TRANSFECTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; HUMAN TISSUE; PHENOTYPE; PROTEIN EXPRESSION; RNA INTERFERENCE; UPREGULATION;

CELL ADHESION; CELL LINE, TUMOR; CYTOSKELETAL PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; NEOPLASM INVASIVENESS; RNA INTERFERENCE; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; WOUND HEALING;

EID: 79954572864     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.11.8.14691     Document Type: Article

References (41)

1. Youn HG, An JY, Choi MG, Noh JH, Sohn TS, Kim S. Recurrence after curative resection of early gastric cancer. Ann Surg Oncol 2010; 17:448-54.
2. Malfertheiner P, Bornschein J, Selgrad M. Role of Helicobacter pylori infection in gastric cancer pathogenesis: a chance for prevention. J Dig Dis 2010; 11:2-11.
3. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345:784-9.
4. Zullo A, Hassan C, Cristofari F, Andriani A, De Francesco V, Ierardi E, et al. Effects of helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma. Clin Gastroenterol Hepatol 2010; 8:105-10.
5. Necchi V, Candusso ME, Tava F, Luinetti O, Ventura U, Fiocca R, et al. Intracellular, intercellular and stromal invasion of gastric mucosa, preneoplastic lesions and cancer by Helicobacter pylori. Gastroenterology 2007; 132:1009-23. (Pubitemid 46440875)
6. Kitadai Y, Sasaki A, Ito M, Tanaka S, Oue N, Yasui W, et al. Helicobacter pylori infection influences expression of genes related to angiogenesis and invasion in human gastric carcinoma cells. Biochem Biophys Res Commun 2003; 311:809-14. (Pubitemid 37393390)
7. Lim JW, Kim H, Kim KH. Cell adhesion-related gene expression by Helicobacter pylori in gastric epithelial AGS cells. Int J Biochem Cell Biol 2003; 35:1284-96. (Pubitemid 36577318)
8. Chang YJ, Wu MS, Lin JT, Chen CC. Helicobacter pylori-induced invasion and angiogenesis of gastric cells is mediated by cyclooxygenase-2 induction through TLR2/TLR9 and promoter regulation. J Immunol 2005; 175:8242-52.
9. Varro A, Noble PJ, Pritchard DM, Kennedy S, Hart CA, Dimaline R, et al. Helicobacter pylori induces plasminogen activator inhibitor 2 in gastric epithelial cells through nuclear factorkappaB and RhoA: implications for invasion and apoptosis. Cancer Res 2004; 64:1695-702. (Pubitemid 38428691)
10. Oliveira MJ, Costa AC, Costa AM, Henriques L, Suriano G, Atherton JC, et al. Helicobacter pylori induces gastric epithelial cell invasion in a c-Met and type IV secretion system-dependent manner. J Biol Chem 2006; 281:34888-96. (Pubitemid 46036528)
11. Oliveira MJ, Costa AM, Costa AC, Ferreira RM, Sampaio P, Machado JC, et al. CagA associates with c-Met, E-cadherin and p120-catenin in a multiproteic complex that suppresses Helicobacter pylori-induced cell-invasive phenotype. J Infect Dis 2009; 200:745-55.
12. Pujuguet P, Del Maestro L, Gautreau A, Louvard D, Arpin M. Ezrin regulates E-cadherin-dependent adherens junction assembly through Rac1 activation. Mol Biol Cell 2003; 14:2181-91. (Pubitemid 36583562)
13. Sato N, Funayama N, Nagafuchi A, Yonemura S, Tsukita S, Tsukita S. A gene family consisting of ezrin, radixin and moesin. Its specific localization at actin filament/plasma membrane association sites. J Cell Sci 1992; 103:131-43.
14. Ren L, Hong SH, Cassavaugh J, Osborne T, Chou AJ, Kim SY, et al. The actin-cytoskeleton linker protein ezrin is regulated during osteosarcoma metastasis by PKC. Oncogene 2009; 28:792-802.
15. Geiger KD, Stoldt P, Schlote W, Derouiche A. Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas. Am J Pathol 2000; 157:1785-93.
16. Deng X, Tannehill-Gregg SH, Nadella MV, He G, Levine A, Cao Y, et al. Parathyroid hormone-related protein and ezrin are upregulated in human lung cancer bone metastases. Clin Exp Metastasis 2007; 24:107-19. (Pubitemid 46669244)
17. Weng WH, Ahlén J, Aström K, Lui WO, Larsson C. Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas. Clin Cancer Res 2005; 11:6198-204. (Pubitemid 41262948)
18. Ohtani K, Sakamoto H, Rutherford T, Chen Z, Satoh K, Naftolin F. Ezrin, a membrane-cytoskeletal linking protein, is involved in the process of invasion of endometrial cancer cells. Cancer Lett 1999; 147:31-8.
19. Mäkitie T, Carpén O, Vaheri A, Kivelä T. Ezrin as a prognostic indicator and its relationship to tumor characteristics in uveal malignant melanoma. Invest Ophthalmol Vis Sci 2001; 42:2442-9. (Pubitemid 32954846)
20. Lim JW, Kim H, Kim JM, Kim JS, Jung HC, Kim KH. Cellular stress-related protein expression in Helicobacter pylori-infected gastric epithelial AGS cells. Int J Biochem Cell Biol 2004; 36:1624-34. (Pubitemid 38625840)
21. Bal N, Yildirim S, Nursal TZ, Bolat F, Kayaselcuk F. Association of ezrin expression in intestinal and diffuse gastric carcinoma with clinicopathological parameters and tumor type. World J Gastroenterol 2007; 13:3726-9. (Pubitemid 47202171)
22. Curto M, McClatchey AI. Ezrin, a metastatic detERMinant? Cancer Cell 2004; 5:113-4.
23. Fais S. A role for ezrin in a neglected metastatic tumor function. Trends Mol Med 2004; 10:249-50. (Pubitemid 38725890)
24. Zhang Y, Hu MY, Wu WZ, Wang ZJ, Zhou K, Zha XL, et al. The membrane-cytoskeleton organizer ezrin is necessary for hepatocellular carcinoma cell growth and invasiveness. J Cancer Res Clin Oncol 2006; 132:685-97. (Pubitemid 44337929)
25. Elliott BE, Meens JA, SenGupta SK, Louvard D, Arpin M. The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells. Breast Cancer Res 2005; 7:365-73.
26. Zeaiter Z, Huynh HQ, Kanyo R, Stein M. CagA of Helicobacter pylori alters the expression and cellular distribution of host proteins involved in cell signaling. FEMS Microbiol Lett 2008; 288:227-34.
27. Tang F, Wang D, Duan C, Huang D, Wu Y, Chen Y, et al. Berberine inhibits metastasis of nasopharyngeal carcinoma 5-8F cells by targeting Rho kinase-mediated Ezrin phosphorylation at threonine 567. J Biol Chem 2009; 284:27456-66.
28. Sizemore S, Cicek M, Sizemore N, Ng KP, Casey G. Podocalyxin increases the aggressive phenotype of breast and prostate cancer cells in vitro through its interaction with ezrin. Cancer Res 2007; 67:6183-91. (Pubitemid 47037499)
29. Kim C, Shin E, Hong S, Chon HJ, Kim HR, Ahn JR, et al. Clinical value of ezrin expression in primary osteosarcoma. Cancer Res Treat 2009; 41:138-44.
30. Xie JJ, Xu LY, Xie YM, Zhang HH, Cai WJ, Zhou F, et al. Roles of ezrin in the growth and invasiveness of esophageal squamous carcinoma cells. Int J Cancer 2009; 124:2549-58.
31. Federici C, Brambilla D, Lozupone F, Matarrese P, de Milito A, Lugini L, et al. Pleiotropic function of ezrin in human metastatic melanomas. Int J Cancer 2009; 124:2804-12.
32. Hopkins AM, Pineda AA, Winfree LM, Brown GT, Laukoetter MG, Nusrat A. Organized migration of epithelial cells requires control of adhesion and protrusion through Rho kinase effectors. Am J Physiol Gastrointest Liver Physiol 2007; 292:806-17.
33. Segal ED, Cha J, Lo J, Falkow S, Tompkins LS. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc Natl Acad Sci USA 1999; 96:14559-64. (Pubitemid 30000689)
34. Wicki A, Lehembre F, Wick N, Hantusch B, Kerjaschki D, Christofori G. Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell 2006; 9:261-72.
35. Machesky LM. Lamellipodia and filopodia in metastasis and invasion. FEBS Letters 2008; 582:2102-11.
36. Faix J, Rottner K. The making of filopodia. Curr Opin Cell Biology 2006; 18:18-25. (Pubitemid 43107603)
37. Small JV, Stradal T, Vignal E, Rottner K. The lamellipodium: where motility begins. Trends Cell Biol 2002; 12:112-20. (Pubitemid 34164650)
38. Borm B, Requardt RP, Herzog V, Kirfel G. Membrane ruffles in cell migration: indicators of inefficient lamellipodia adhesion and compartments of actin filament reorganization. Exp Cell Res 2005; 302:83-95. (Pubitemid 39482370)
39. Gautreau A, Poullet P, Louvard D, Arpin M. Ezrin, a plasma membrane-microfilament linker, signals cell survival through the phosphatidylinositol 3-kinase/Akt pathway. Proc Natl Acad Sci USA 1999; 96:7300-5. (Pubitemid 29299656)
40. Algrain M, Turunen O, Vaheri A, Louvard D, Arpin M. Ezrin contains cytoskeleton and membrane binding domains accounting for its proposed role as a membrane-cytoskeletal linker. J Cell Biol 1993; 120:129-39.
41. Geiger TR, Peeper DS. Metastasis mechanisms. Biochimica et Biophysica Acta 2009; 1796:293-308.